---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-038888"
form_type: "8-K"
ticker: "HRMY"
cik: "0001802665"
company_name: "Harmony Biosciences Holdings, Inc."
filed_at: "2026-04-02T23:59:59+00:00"
generated_at: "2026-05-15T07:51:58.639781+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Harmony Biosciences appoints Peter Anastasiou as COO; adds Troy Ignelzi to Board

## Summary
- Peter Anastasiou named SEVP and COO, effective April 2, 2026; resigns from Board.
- Troy Ignelzi appointed Class III director, filling vacancy; will serve on Audit and Compensation Committees.
- Antonio Gracias will not stand for re-election at 2026 annual meeting; term ends May 14, 2026.
- Geno J. Germano nominated for election to Board at 2026 annual meeting.
- Anastasiou receives $600K base salary, 55% bonus target, $3.7M option award with 4-year vest.

## SEC filing metadata
- accession: 0001104659-26-038888
- form_type: 8-K
- ticker: HRMY
- cik: 0001802665
- company_name: Harmony Biosciences Holdings, Inc.
- filed_at: 2026-04-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802665/000110465926038888/0001104659-26-038888-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802665/000110465926038888/hrmy-20260331x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-038888
- JSON: https://secwatch.observer/filing/0001104659-26-038888.json
- Plain text: https://secwatch.observer/filing/0001104659-26-038888.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.